Spermine oxidase mediates Helicobacter pylori-induced gastric inflammation, DNA damage, and carcinogenic signaling

AUTHORS

Sierra JCJohanna C , Piazuelo MBM Blanca , Luis PBPaula B , Barry DPDaniel P , Allaman MMMargaret M , Asim MMohammad , Sebrell TAThomas A , Finley JLJordan L , Rose KLKristie L , Hill SSalisha , Holshouser SLSteven L , Casero RARobert A , Cleveland JLJohn L , Woster PMPatrick M , Schey KLKevin L , Bimczok DDiane , Schneider CClaus , Gobert APAlain P , Wilson KTKeith T . Oncogene. 2020 4 29; 39(22). 4465-4474

PMID: 32350444[PubMed].

ABSTRACT

Helicobacter pylori infection is the main risk factor for the development of gastric cancer, the third leading cause of cancer death worldwide. H. pylori colonizes the human gastric mucosa and persists for decades. The inflammatory response is ineffective in clearing the infection, leading to disease progression that may result in gastric adenocarcinoma. We have shown that polyamines are regulators of the host response to H. pylori, and that spermine oxidase (SMOX), which metabolizes the polyamine spermine into spermidine plus HO, is associated with increased human gastric cancer risk. We now used a molecular approach to directly address the role of SMOX, and demonstrate that Smox-deficient mice exhibit significant reductions of gastric spermidine levels and H. pylori-induced inflammation. Proteomic analysis revealed that cancer was the most significantly altered functional pathway in Smox gastric organoids. Moreover, there was also less DNA damage and β-catenin activation in H. pylori-infected Smox mice or gastric organoids, compared to infected wild-type animals or gastroids. The link between SMOX and β-catenin activation was confirmed in human gastric organoids that were treated with a novel SMOX inhibitor. These findings indicate that SMOX promotes H. pylori-induced carcinogenesis by causing inflammation, DNA damage, and activation of β-catenin signaling.